Hypertrophic cardiomyopathy pathophysiology: Difference between revisions
(Created page with "__NOTOC__ {{Hypertrophic cardiomyopathy}} {{CMG}}; {{AE}} ==Overview== The exact pathogenesis of [disease name] is not fully understood. OR It is thought that [disease nam...") |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview== | ||
The exact pathogenesis of | The exact pathogenesis of Hypertrophic cardiomyopathy is not fully understood. | ||
OR | OR | ||
It is thought that | It is thought that Hypertrophic cardiomyopathy is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3]. | ||
OR | OR | ||
| Line 25: | Line 25: | ||
OR | OR | ||
The progression to | The progression to Hypertrophic cardiomyopathy usually involves the [molecular pathway]. | ||
OR | OR | ||
| Line 36: | Line 36: | ||
===Pathogenesis=== | ===Pathogenesis=== | ||
*The exact pathogenesis of | *The exact pathogenesis of Hypertrophic cardiomyopathy is not completely understood. | ||
OR | OR | ||
*It is understood that | *It is understood that Hypertrophic cardiomyopathy is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3]. | ||
*[Pathogen name] is usually transmitted via the [transmission route] route to the human host. | *[Pathogen name] is usually transmitted via the [transmission route] route to the human host. | ||
*Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell. | *Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell. | ||
*[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells]. | *[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells]. | ||
*The progression to | *The progression to Hypertrophic cardiomyopathy usually involves the [molecular pathway]. | ||
*The pathophysiology of [disease/malignancy] depends on the histological subtype. | *The pathophysiology of [disease/malignancy] depends on the histological subtype. | ||
==Genetics== | ==Genetics== | ||
Hypertrophic cardiomyopathy is transmitted in [mode of genetic transmission] pattern. | |||
OR | OR | ||
Genes involved in the pathogenesis of | Genes involved in the pathogenesis of Hypertrophic cardiomyopathy include: | ||
*[Gene1] | *[Gene1] | ||
*[Gene2] | *[Gene2] | ||
| Line 57: | Line 57: | ||
OR | OR | ||
The development of | The development of Hypertrophic cardiomyopathy is the result of multiple genetic mutations such as: | ||
*[Mutation 1] | *[Mutation 1] | ||
| Line 64: | Line 64: | ||
==Associated Conditions== | ==Associated Conditions== | ||
Conditions associated with | Conditions associated with Hypertrophic cardiomyopathy include: | ||
*[Condition 1] | *[Condition 1] | ||
| Line 71: | Line 71: | ||
==Gross Pathology== | ==Gross Pathology== | ||
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of | On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of Hypertrophic cardiomyopathy. | ||
==Microscopic Pathology== | ==Microscopic Pathology== | ||
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of | On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of Hypertrophic cardiomyopathy. | ||
==References== | ==References== | ||
Revision as of 16:45, 22 November 2019
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy pathophysiology On the Web |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
The exact pathogenesis of Hypertrophic cardiomyopathy is not fully understood.
OR
It is thought that Hypertrophic cardiomyopathy is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to Hypertrophic cardiomyopathy usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.
Pathophysiology
Physiology
The normal physiology of [name of process] can be understood as follows:
Pathogenesis
- The exact pathogenesis of Hypertrophic cardiomyopathy is not completely understood.
OR
- It is understood that Hypertrophic cardiomyopathy is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
- [Pathogen name] is usually transmitted via the [transmission route] route to the human host.
- Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
- [Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
- The progression to Hypertrophic cardiomyopathy usually involves the [molecular pathway].
- The pathophysiology of [disease/malignancy] depends on the histological subtype.
Genetics
Hypertrophic cardiomyopathy is transmitted in [mode of genetic transmission] pattern.
OR
Genes involved in the pathogenesis of Hypertrophic cardiomyopathy include:
- [Gene1]
- [Gene2]
- [Gene3]
OR
The development of Hypertrophic cardiomyopathy is the result of multiple genetic mutations such as:
- [Mutation 1]
- [Mutation 2]
- [Mutation 3]
Associated Conditions
Conditions associated with Hypertrophic cardiomyopathy include:
- [Condition 1]
- [Condition 2]
- [Condition 3]
Gross Pathology
On gross pathology, [feature1], [feature2], and [feature3] are characteristic findings of Hypertrophic cardiomyopathy.
Microscopic Pathology
On microscopic histopathological analysis, [feature1], [feature2], and [feature3] are characteristic findings of Hypertrophic cardiomyopathy.